Brain Protection and Nerve Health New research on BPC-157 nasal spray benefits includes brain protection effects
Apr 28th, 2026 How Retatrutide Impacts Weight Loss and Metabolism Retatrutide is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors that has shown significant weight loss and metabolic benefits in trials, but it is not yet FDA-approved and remains available only in clinical studies
In another study, intraperitoneal administration of BPC-157 (2ug/kg) improved motor function, reduced lesions in white and grey matter and relieved neuronal damage in rats with spinal cord injury [5] Research in the alkali burn rat models has shown that topical BPC-157 can speed up wound closure
However, the complexity of their structures significantly restricts our understanding of their biological activities, thus it would be worthwhile to carry out more systematic research studies in the future (Hu et al., 2019)
